Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States ...

For some patients with atrial fibrillation (Afib, AF) and valvular heart disease (VHD), direct oral anticoagulants (DOACs) appeared to offer better prevention of stroke and thromboembolic events ...